Susan J. Perlmutter
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Susan J. Perlmutter.
Biological Psychiatry | 1999
Marjorie A. Garvey; Susan J. Perlmutter; Albert J. Allen; Susan D. Hamburger; Lorraine Lougee; Henrietta L. Leonard; M.Elizabeth Witowski; Billinda Dubbert; Susan E. Swedo
BACKGROUND Some children with obsessive-compulsive disorder (OCD) and tic disorders appear to have symptom exacerbations triggered by group A beta-hemolytic streptococcal infections in a manner that is similar to rheumatic fever and its neurologic variant, Sydenhams chorea. Because penicillin prophylaxis has proven to be effective in preventing recurrences of rheumatic fever, it was postulated that it might also prevent streptococcal-triggered neuropsychiatric symptom exacerbations in children with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS). These children are identified by five clinical characteristics: presence of OCD or tic disorder, prepubertal onset, episodic symptom course, neurologic abnormalities (i.e., choreiform movements) and streptococcal-triggered symptom exacerbations. METHODS Thirty-seven children with PANDAS were enrolled in an 8 month, double-blind, balanced cross-over study. Patients were randomized to receive either 4 months of the active compound (twice daily oral 250 mg penicillin V) followed by 4 months of placebo, or placebo followed by penicillin V. Tic, OCD, and other psychiatric symptoms were monitored monthly. Throat cultures and streptococcal antibody titers were also obtained. RESULTS There were an equal number of infections in both the active and placebo phases of the study. There was no significant change seen in either the obsessive-compulsive or tic symptom severity between the two phases. CONCLUSIONS Because of the failure to achieve an acceptable level of streptococcal prophylaxis, no conclusions can be drawn from this study regarding the efficacy of penicillin prophylaxis in preventing tic or OCD symptom exacerbations. Future studies should employ a more effective prophylactic agent, and include a larger sample size.
Journal of the American Academy of Child and Adolescent Psychiatry | 2000
Lorraine Lougee; Susan J. Perlmutter; Rob Nicolson; Marjorie A. Garvey; Susan E. Swedo
OBJECTIVE To determine the rates of psychiatric disorders in the first-degree relatives of children with infection-triggered obsessive-compulsive disorder (OCD) and/or tics (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections; PANDAS). METHOD The probands of this study were 54 children with PANDAS (n = 24 with a primary diagnosis of OCD; n = 30 with a primary diagnosis of a tic disorder). One hundred fifty-seven first-degree relatives (100 parents [93%] and 57 siblings [100%]) were evaluated for the presence of a tic disorder. One hundred thirty-nine first-degree relatives (100 parents [93%] and 39 of 41 siblings over the age of 6 [95%]) were evaluated with clinical and structured psychiatric interviews to determine the presence of subclinical OCD, OCD, and other DSM-IV Axis I disorders. RESULTS Twenty-one probands (39%) had at least one first-degree relative with a history of a motor or vocal tic; 6 mothers (11%), 9 fathers (19%), and 8 siblings (16%) received this diagnosis. Fourteen probands (26%) had at least one first-degree relative with OCD; 10 mothers (19%), 5 fathers (11%), and 2 siblings (5%), received this diagnosis. An additional 8 parents (8%) and 3 siblings (8%) met criteria for subclinical OCD. Eleven parents (11%) had obsessive-compulsive personality disorder. CONCLUSIONS The rates of tic disorders and OCD in first-degree relatives of pediatric probands with PANDAS are higher than those reported in the general population and are similar to those reported previously for tic disorders and OCD. Further study is warranted to determine the nature of the relationship between genetic and environmental factors in PANDAS.
American Journal of Psychiatry | 1998
Susan E. Swedo; Henrietta L. Leonard; Marjorie A. Garvey; Barbara Mittleman; Albert J. Allen; Susan J. Perlmutter; Sara Dow; Jason Zamkoff; Billinda Dubbert; Lorraine Lougee
The Lancet | 1999
Susan J. Perlmutter; Susan F. Leitman; Marjorie A. Garvey; Susan D. Hamburger; Elad Feldman; Henrietta L. Leonard; Susan E. Swedo
American Journal of Psychiatry | 2000
Jay N. Giedd; Judith L. Rapoport; Marjorie A. Garvey; Susan J. Perlmutter; Susan E. Swedo
American Journal of Psychiatry | 1998
Susan J. Perlmutter; Marjorie A. Garvey; Xavier Castellanos; Barbara Mittleman; Jay N. Giedd; Judith L. Rapoport; Susan E. Swedo
FOCUS | 2004
Susan E. Swedo; Henrietta L. Leonard; Marjorie A. Garvey; Barbara Mittleman; Albert J. Allen; Susan J. Perlmutter; Lorraine Lougee; Sara Dow; Jason Zamkoff; Billinda Dubbert
Child and Adolescent Psychiatric Clinics of North America | 1999
Henrietta L. Leonard; Susan E. Swedo; Marjorie A. Garvey; Douglas Beer; Susan J. Perlmutter; Lorraine Lougee; Mai Karitani; Billinda Dubbert
Journal of the American Academy of Child and Adolescent Psychiatry | 1999
Molly C. Henry; Susan J. Perlmutter; Susan E. Swedo
Child and Adolescent Psychiatric Clinics of North America | 1995
Susan J. Perlmutter